Product Introduction
Safkit Tablet combines antiviral agents Sofosbuvir, Velpatasvir, and Ribavirin to effectively inhibit HCV replication, improving cure rates in chronic hepatitis C infection across various genotypes.
Uses of Safkit 1000/150/1000 mg Tablet
-
Treatment of chronic hepatitis C virus (HCV) infection
-
Used for multiple HCV genotypes
-
Helps achieve sustained virologic response (SVR) and viral clearance
Benefits of Safkit 1000/150/1000 mg Tablet
-
Highly effective antiviral therapy
-
Pan-genotypic treatment option
-
Oral administration with good tolerability
-
Improves liver health and reduces risk of liver damage
Composition
-
Sofosbuvir 1000 mg
-
Velpatasvir 150 mg
-
Ribavirin 1000 mg
Side Effects
-
Fatigue
-
Headache
-
Nausea
-
Anemia (due to Ribavirin)
-
Insomnia
Safety Advice
-
Use strictly under medical supervision.
-
Not recommended during pregnancy due to Ribavirin.
-
Regular blood tests to monitor anemia and liver function.
-
Avoid alcohol and hepatotoxic substances during treatment.
-
Store in a cool, dry place away from direct sunlight.
